Maravai LifeSciences Holdings Inc banner

Maravai LifeSciences Holdings Inc
F:MAR

Watchlist Manager
Maravai LifeSciences Holdings Inc Logo
Maravai LifeSciences Holdings Inc
F:MAR
Watchlist
Price: 3.12 EUR 5.41%
Market Cap: €786m

Wall St Price Targets

MAR Price Targets Summary
Maravai LifeSciences Holdings Inc

Wall Street analysts forecast MAR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MAR is 3.92 EUR with a low forecast of 3.37 EUR and a high forecast of 4.38 EUR.

Lowest Forecast
Price Target
3.37 EUR
8% Upside
Average Forecast
Price Target
3.92 EUR
26% Upside
Highest Forecast
Price Target
4.38 EUR
41% Upside
Maravai LifeSciences Holdings Inc Competitors:
Price Targets
MNPR
Monopar Therapeutics Inc
116% Upside
BSRR
Sierra Bancorp
8% Upside
GLSI
Greenwich Lifesciences Inc
104% Upside

Revenue
Forecast

4% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
4% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

Over the last 6 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 8 years is 11%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-19%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-19%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is MAR's stock price target?
Price Target
3.92 EUR

According to Wall Street analysts, the average 1-year price target for MAR is 3.92 EUR with a low forecast of 3.37 EUR and a high forecast of 4.38 EUR.

What is the Revenue forecast for Maravai LifeSciences Holdings Inc?
Projected CAGR
11%

Over the last 6 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 8 years is 11%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett